13From milestone to mainstream
The story that began with Volta's jolt and a Paris operating theatre ends — for now — with the most successful neural prosthesis ever built, implanted in well over a million people and given to infants as a matter of routine. The cochlear implant is widely described as the first device to substantially restore a human sense, and in 2013 its principal pioneers shared the Lasker Award, often a precursor to the Nobel. This closing module steps back from the chronology to ask what the whole history means: what it teaches about how medical breakthroughs actually happen, what remains unfinished, and how this human prologue connects to everything the rest of the atlas will examine in detail.
FWhat it became
Measured against where it started, the cochlear implant's arrival is extraordinary. A device that once offered a few deaf adults the rhythm of speech and an aid to lip-reading now routinely delivers open-set speech understanding and telephone use, is implanted bilaterally in infants, and serves well over a million recipients across the world. It is, by common assessment, the most successful neural prosthesis to date and the first device to substantially restore a lost human sense.
FThe Lasker Award
In 2013, the Lasker~DeBakey Clinical Medical Research Award — often a forerunner of the Nobel — was given to Graeme Clark, Ingeborg Hochmair and Blake Wilson“for the development of the modern cochlear implant.” The trio neatly captures the chapter's three strands: Clark and Hochmair built the multichannel devices (Australia and Austria), and Wilson devised the coding strategy that made them deliver speech. The award marked the field's full passage from contested experiment to celebrated triumph.[2013]
CWhat the history teaches
Three lessons run through the whole story. First, a correct idea can sit unused for a long time until its enabling tools mature — Volta to working device took nearly two centuries. Second, breakthroughs survive scepticism: almost every milestone here was opposed by serious experts, and the field advanced because its pioneers persisted on the evidence. Third, and most practical, how you use a technology can matter as much as the technology— the largest single gain came not from new hardware but from the CIS coding strategy. These are worth carrying into any judgement about today's emerging therapies.
CThe unfinished story — access
The history is a triumph, but not a finished one. The implant's benefits are still distributed deeply unequally: in much of the world, including India, the great majority of people who could benefit never receive a device, for reasons of cost, awareness, and the supply of trained professionals (Chapter 5). The next chapter of the cochlear implant's history — still being written — is less about the device than about reaching the people who need it.
FInto the rest of the atlas
Everything that follows in this atlas is the detailed working-out of what these pioneers made possible. The physiology the implant exploits, the plastic brain it depends on, the epidemiology that defines its need, the genetics that shape its result, and the objective measures that verify it works — each is a facet of the device whose human story you have just followed. The history is the prologue; the science is the rest of the book.
What is the most important qualification to that view?
Who shared the 2013 Lasker Award for the modern cochlear implant?
What is the cochlear implant's principal unfinished challenge?